z-logo
open-access-imgOpen Access
Genomic Characterization of Prostatic Ductal Adenocarcinoma Identifies a High Prevalence of DNA Repair Gene Mutations
Author(s) -
Michael T. Schweizer,
Emmanuel S. Antonarakis,
Tarek A. Bismar,
Liana B. Guedes,
Heather H. Cheng,
Maria Tretiakova,
Funda VakarLopez,
Nola Klemfuss,
Eric Q. Konnick,
Elahe A. Mostaghel,
Andrew C. Hsieh,
Peter S. Nelson,
Evan Y. Yu,
Bruce Montgomery,
Lawrence D. True,
Jonathan I. Epstein,
Tamara L. Lotan,
Colin C. Pritchard
Publication year - 2019
Publication title -
jco precision oncology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.405
H-Index - 22
ISSN - 2473-4284
DOI - 10.1200/po.18.00327
Subject(s) - dna repair , mutation , prostate cancer , cancer research , wnt signaling pathway , cancer , gene , biology , medicine , adenocarcinoma , dna sequencing , germline mutation , genetics
Ductal prostate cancer (dPC) is a rare variant of prostatic adenocarcinoma associated with poor outcomes. Although its histopathologic features are well characterized, the underlying molecular hallmarks of this aggressive subtype are not well described. We sought to provide a comprehensive overview of the spectrum of mutations associated with dPC.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom